An injectable hydrogel platform forms a lubricating depot inside the joint after a single minimally invasive injection, allowing drug-loaded nanocarriers to remain in place for several weeks and release medication gradually. Osteoarthritis (OA) is one of the world’s major causes…
Continue reading with a subscription
This article is available to subscribers. Subscribe to read it in full, or sign in if you already have an account.